This topic contains a solution. Click here to go to the answer

Author Question: Suctioning is discontinued if the client experiences: A. Coughing B. A decrease in pulse from 84 ... (Read 26 times)

bucstennis@aim.com

  • Hero Member
  • *****
  • Posts: 532
Suctioning is discontinued if the client experiences:
 
  A. Coughing
  B. A decrease in pulse from 84 beats per minute to 60 beats per minute
  C. An increase in pulse from 84 beats per minute to 124 beats per minute
  D. A reduction of oxygen saturation from 97 to 94

Question 2

The nurse is preparing to give an intramuscular injection to a toddler. To decrease pain, EMLA cream is applied to the injection site at least ______ hour(s) before administration of the injection.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ciecieme

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

B
B. If the client's pulse drops more than 20 beats per minute, cease suctioning.
A. Client should cough. If client gags or becomes nauseated, catheter is most likely in esophagus and must be removed.
C. If the client's pulse increases more than 40 beats per minute, cease suctioning.
D. If the client's pulse oximetry falls below 90 or 5 from baseline, cease suctioning.

Answer to Question 2

1
EMLA cream should be applied to the injection site at least 1 hour before IM injection to decrease pain.




bucstennis@aim.com

  • Member
  • Posts: 532
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


kishoreddi

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library